CR20140380A - Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina - Google Patents

Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina

Info

Publication number
CR20140380A
CR20140380A CR20140380A CR20140380A CR20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A
Authority
CR
Costa Rica
Prior art keywords
pirazolopirimidinyl
ubiquitine
inhibitors
activating enzyme
formula
Prior art date
Application number
CR20140380A
Other languages
English (en)
Spanish (es)
Inventor
Roushan Afroze
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Mario Girard
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Yingchun Ye
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of CR20140380A publication Critical patent/CR20140380A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
CR20140380A 2012-02-17 2014-08-12 Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina CR20140380A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17
PCT/US2013/026113 WO2013123169A1 (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Publications (1)

Publication Number Publication Date
CR20140380A true CR20140380A (es) 2014-10-28

Family

ID=48982730

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140380A CR20140380A (es) 2012-02-17 2014-08-12 Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina

Country Status (30)

Country Link
US (4) US9290500B2 (https=)
EP (3) EP2814791A4 (https=)
JP (1) JP6122877B2 (https=)
KR (1) KR20140123104A (https=)
CN (1) CN104136399B (https=)
AR (1) AR092797A1 (https=)
BR (1) BR112014020365B1 (https=)
CA (1) CA2864672C (https=)
CL (1) CL2014002181A1 (https=)
CO (1) CO7071135A2 (https=)
CR (1) CR20140380A (https=)
DO (1) DOP2014000187A (https=)
EA (1) EA035020B1 (https=)
EC (1) ECSP14019113A (https=)
ES (1) ES2739150T3 (https=)
GE (1) GEP201706687B (https=)
HK (1) HK1201817A1 (https=)
IL (1) IL234016A0 (https=)
MA (1) MA35932B1 (https=)
MX (1) MX352963B (https=)
NZ (1) NZ628969A (https=)
PE (1) PE20142244A1 (https=)
PH (1) PH12014501832A1 (https=)
SG (2) SG10201606581RA (https=)
TN (1) TN2014000351A1 (https=)
TW (1) TWI593688B (https=)
UA (1) UA116534C2 (https=)
UY (1) UY34629A (https=)
WO (1) WO2013123169A1 (https=)
ZA (1) ZA201406103B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
EP2814791A4 (en) 2012-02-17 2015-08-19 Millennium Pharm Inc PYRAZOLOPYRIMIDINYL INHIBITORS OF ACTIVATION ENZYME OF UBIQUITIN
EP2879681A4 (en) 2012-08-03 2015-12-23 Millennium Pharm Inc INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6
JP6378759B2 (ja) 2013-07-02 2018-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme
JP6697453B2 (ja) * 2014-10-29 2020-05-20 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. ユビキチン活性化酵素阻害物質及び放射線の投与
WO2016069392A1 (en) 2014-10-29 2016-05-06 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
AU2019370200B2 (en) 2018-10-30 2024-12-19 Kronos Bio, Inc. Compounds, compositions, and methods for modulating CDK9 activity
WO2022253188A1 (en) * 2021-05-31 2022-12-08 Impact Therapeutics (Shanghai) , Inc Nitrogen-containing fused heteroaromatic bicyclic compounds as usp1 inhibitors and the use thereof
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003073989A2 (en) 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
MY137843A (en) 2002-09-04 2009-03-31 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors
CA2497444C (en) 2002-09-04 2010-11-30 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US20070179161A1 (en) 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) * 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
US20050130974A1 (en) 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
WO2006002284A1 (en) 2004-06-22 2006-01-05 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
RS52458B (sr) 2005-02-04 2013-02-28 Millennium Pharmaceuticals Inc. Inhibitori e1 aktivirajućih enzima
TWI333953B (en) 2005-10-06 2010-12-01 Schering Corp Pyrazolopyrimidines as protein kinase inhibitors
EA024006B1 (ru) 2006-02-02 2016-08-31 Миллениум Фармасьютикалз, Инк. Ингибиторы е1 активирующих ферментов
EP1992008A1 (en) * 2006-02-28 2008-11-19 Sez Ag Device and method for liquid treating disc-like articles
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
ZA200900670B (en) * 2006-08-08 2010-04-28 Millennium Pharm Inc Heteroaryl compounds useful as inhititors of E1 activating enzymes
JP5539864B2 (ja) 2007-06-12 2014-07-02 アカオゲン,インコーポレーテッド 抗菌剤
EP2178880B1 (en) 2007-08-02 2017-10-04 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
EP2430026A1 (en) 2009-05-14 2012-03-21 Millennium Pharmaceuticals, Inc. Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
MX2012010115A (es) 2010-03-01 2013-02-26 Gtx Inc Compuestos para el tratamiento de cancer.
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
JP6038150B2 (ja) 2011-08-24 2016-12-07 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Nedd8活性化酵素阻害剤
EP2814791A4 (en) 2012-02-17 2015-08-19 Millennium Pharm Inc PYRAZOLOPYRIMIDINYL INHIBITORS OF ACTIVATION ENZYME OF UBIQUITIN
EP2879681A4 (en) 2012-08-03 2015-12-23 Millennium Pharm Inc INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6
JP6378759B2 (ja) 2013-07-02 2018-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Also Published As

Publication number Publication date
MX352963B (es) 2017-12-15
CO7071135A2 (es) 2014-09-30
DOP2014000187A (es) 2014-10-15
EP3173413A1 (en) 2017-05-31
CN104136399B (zh) 2018-08-07
JP6122877B2 (ja) 2017-04-26
ECSP14019113A (es) 2015-09-30
EP2814791A4 (en) 2015-08-19
CL2014002181A1 (es) 2014-12-12
EP3536692A1 (en) 2019-09-11
NZ628969A (en) 2017-03-31
US9290500B2 (en) 2016-03-22
EA035020B1 (ru) 2020-04-17
AR092797A1 (es) 2015-05-06
MX2014009944A (es) 2014-11-10
SG10201606581RA (en) 2016-09-29
BR112014020365A2 (pt) 2020-12-22
TWI593688B (zh) 2017-08-01
BR112014020365B1 (pt) 2023-02-23
HK1201817A1 (en) 2015-09-11
PH12014501832A1 (en) 2014-11-17
JP2015508775A (ja) 2015-03-23
US20170217968A1 (en) 2017-08-03
EA201400831A1 (ru) 2014-12-30
ZA201406103B (en) 2017-11-29
WO2013123169A1 (en) 2013-08-22
US20130217682A1 (en) 2013-08-22
EP3536692B1 (en) 2021-04-07
GEP201706687B (en) 2017-06-26
PE20142244A1 (es) 2015-01-07
US20160244455A1 (en) 2016-08-25
EP3173413B1 (en) 2019-05-01
TW201345909A (zh) 2013-11-16
EP2814791A1 (en) 2014-12-24
CN104136399A (zh) 2014-11-05
SG11201404757WA (en) 2014-09-26
CA2864672A1 (en) 2013-08-22
US9796725B2 (en) 2017-10-24
TN2014000351A1 (en) 2015-12-21
IL234016A0 (en) 2014-09-30
US9663525B2 (en) 2017-05-30
MA35932B1 (fr) 2014-12-01
CA2864672C (en) 2018-01-09
KR20140123104A (ko) 2014-10-21
UA116534C2 (uk) 2018-04-10
US20140088096A9 (en) 2014-03-27
UY34629A (es) 2013-09-02
US20170369499A1 (en) 2017-12-28
US10202389B2 (en) 2019-02-12
ES2739150T3 (es) 2020-01-29

Similar Documents

Publication Publication Date Title
CR20140380A (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
UA110338C2 (xx) Хімічні сполуки
BR112013016595A2 (pt) inibidores de neprilisina
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
EA201792021A1 (ru) Ингибитор jak
UA111382C2 (uk) Інгібітори протеїнкінази
EA201290880A1 (ru) Новые соединения - ингибиторы фермента
UY34092A (es) Nuevos compuestos como inhibidores de jak
UY34216A (es) Nuevos compuestos que inhiben la actividad de la Lp-PLA2
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
EA201490724A1 (ru) Замещенные соединения тетрагидроизохинолина в качестве ингибиторов фактора xia
UY34559A (es) Inhibidores de bromodominios
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34851A (es) Inhibidores macrocíclicos de virus flaviviridae
CR20140024A (es) Compuestos inhibidores de metaloenzimas
UY33937A (es) Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
HUE054473T2 (hu) Eljárás HIV-integráz inhibitor hatású vegyületek elõállítására
BR112014013974A2 (pt) derivados de sulfonamida benzílicos como moduladores de rorc
CR20130539A (es) Triazolopiridinas
IN2014CN04558A (https=)